COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,284 Articles (22,759 medRxiv, 8,525 bioRxiv)

Most recent first Previous |  Page 2888: Articles 28871-28880  | Next

Extensions of the SEIR Model for the Analysis of Tailored Social Distancing and Tracing Approaches to Cope with COVID-19
Grimm, V., Mengel, F., Schmidt, M.
10.1101/2020.04.24.20078113 — Posted: 2020-04-29
Predicting COVID-19 peaks around the world
TSALLIS, C., TIRNAKLI, U.
10.1101/2020.04.24.20078154 — Posted: 2020-04-29
The reproductive index from SEIR model of Covid-19 epidemic in Asean
udomsamuthirun, p., Chanilkul, G., Tongkhonburi, P., Meesubthong, C.
10.1101/2020.04.24.20078287 — Posted: 2020-04-29
COVID-19 in Africa -- outbreak despite interventions?
Schröder, M., Bossert, A., Kersting, M., Aeffner, S., Coetzee, J., Timme, M., Schlüter, J.
10.1101/2020.04.24.20077891 — Posted: 2020-04-29
Sequential informed pooling approach to detect SARS-CoV2 infection
Millioni, R., Mortarino, C.
10.1101/2020.04.24.20077966 — Posted: 2020-04-29
Contextualizing covid-19 spread: a county level analysis, urban versus rural, and implications for preparing for the next wave
Rao, J. S., Zhang, H., Mantero, A.
10.1101/2020.04.24.20078204 — Posted: 2020-04-29
A model for 2019-nCoV infection with treatment
Chatterjee, A. N., Basir, F. A.
10.1101/2020.04.24.20077958 — Posted: 2020-04-29
Investigating duration and intensity of Covid-19 social-distancing strategies
Neuwirth, C., Gruber, C., Murphy, T.
10.1101/2020.04.24.20078022 — Posted: 2020-04-29 Discussion: Onsite
Towards the next phase: evaluation of serological assays for diagnostics and exposure assessment.
GeurtsvanKessel, C. H., OKBA, N. M. A., Igloi, Z., Embregts, C. W. E., Laksono, B. M., Leijten, L., Rahamat-Langendoen, J., van den Akker, J. P. C., van Kampen, J. J. A., van der Eijk, A. A., van Binnendijk, R. S., Hangman, B., Koopmans, M.
10.1101/2020.04.23.20077156 — Posted: 2020-04-29
Role of Drugs Affecting the Renin-Angiotensin-Aldosterone System on Susceptibility and Severity of COVID-19: A Large Case-Control Study from Zheijang Province, China.
Yan, H., Valdes, A. M., Vijay, A., Wang, S., Liang, L., Yang, S., Wang, H., Tan, X., Du, J., Jin, S., Huang, K., Jiang, F., Zhang, S., Zheng, N., Hu, Y., Cai, T., Aithal, G. P.
10.1101/2020.04.24.20077875 — Posted: 2020-04-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).